BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38401515)

  • 1. Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assay.
    Schromm AB; Correa W; Gisch N; Steiniger F; Richter W; Martinez-de-Tejada G; Brandenburg K; von Wintzingerode F
    Biomed Pharmacother; 2024 Apr; 173():116286. PubMed ID: 38401515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) Phenomenon.
    Correa W; Brandenburg K; Zähringer U; Ravuri K; Khan T; von Wintzingerode F
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide Structure and the Phenomenon of Low Endotoxin Recovery.
    Gorman A; Golovanov AP
    Eur J Pharm Biopharm; 2022 Nov; 180():289-307. PubMed ID: 36272656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different sample treatment methods on Low Endotoxin Recovery Phenomenon.
    Bu R; Deng X; Cao Y; Jin J; Mai B; Meng K; Liu X; Chi JC; Zhang Y; Qiu F
    J Microbiol Methods; 2021 Jul; 186():106241. PubMed ID: 33992679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masking of endotoxin in surfactant samples: Effects on Limulus-based detection systems.
    Reich J; Lang P; Grallert H; Motschmann H
    Biologicals; 2016 Sep; 44(5):417-22. PubMed ID: 27464990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample Treatments That Solve Low Endotoxin Recovery Issues.
    Tsuchiya M
    PDA J Pharm Sci Technol; 2019; 73(5):433-442. PubMed ID: 30902837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low endotoxin recovery and its impact on endotoxin detection.
    Cao Y; Zhang Y; Qiu F
    Biopolymers; 2021 Nov; 112(11):e23470. PubMed ID: 34407207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the kinetics and mechanism of low endotoxin recovery in a matrix for biopharmaceutical drug products.
    Reich J; Tamura H; Nagaoka I; Motschmann H
    Biologicals; 2018 May; 53():1-9. PubMed ID: 29685804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It is time to reconsider the use of naturally-occurring endotoxins in endotoxin recovery studies: Part 2 of a BioPhorum harmonized endotoxin recovery study.
    Bolden J; Knight M; Montz J; One J; Stockman S; Jones SP
    Biologicals; 2024 Jun; 87():101779. PubMed ID: 38908364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against a bacterial endotoxin masking effect in biologic drug products by limulus amebocyte lysate detection.
    Bolden JS; Claerbout ME; Miner MK; Murphy MA; Smith KR; Warburton RE
    PDA J Pharm Sci Technol; 2014; 68(5):472-7. PubMed ID: 25336418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovering What Matters: High Protein Recovery after Endotoxin Removal from LPS-Contaminated Formulations Using Novel Anti-Lipid A Antibody Microparticle Conjugates.
    Casonato Melo C; Fux AC; Himly M; Bastús NG; Schlahsa L; Siewert C; Puntes V; Duschl A; Gessner I; Fauerbach JA
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Validation Study of the Limulus Amebocyte Lysate Test as an End-Product Endotoxin Test for Polyvalent Horse Snake Antivenom.
    Sheraba NS; Diab MR; Yassin AS; Amin MA; Zedan HH
    PDA J Pharm Sci Technol; 2019; 73(6):562-571. PubMed ID: 30770487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin recovery using limulus amebocyte lysate (LAL) assay.
    Bolden JS; Warburton RE; Phelan R; Murphy M; Smith KR; De Felippis MR; Chen D
    Biologicals; 2016 Sep; 44(5):434-40. PubMed ID: 27470947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monocyte activation test detects potentiated cytokine release resulting from the synergistic effect of endotoxin and non-endotoxin pyrogens.
    Solati S; Zhang T; Timman S
    Innate Immun; 2022 Apr; 28(3-4):130-137. PubMed ID: 35491666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological Activity of Masked Endotoxin.
    Schwarz H; Gornicec J; Neuper T; Parigiani MA; Wallner M; Duschl A; Horejs-Hoeck J
    Sci Rep; 2017 Mar; 7():44750. PubMed ID: 28317862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Limulus amebocyte lysate endotoxin assay: current status.
    Pearson FC
    Am J Med Technol; 1979 Aug; 45(8):704-9. PubMed ID: 573551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of
    Marius M; Vacher F; Bonnevay T
    PDA J Pharm Sci Technol; 2020; 74(4):394-407. PubMed ID: 32179709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of Turbidimetric Limulus Amebocyte Lysate Assay for the Recovery of Endotoxin Interacted with Commonly Used Antimicrobial Agents of Endodontic Therapy.
    Marinho AC; Polay AR; Gomes BP
    J Endod; 2015 Oct; 41(10):1653-9. PubMed ID: 26254546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of limulus amebocyte lysate and recombinant endotoxin alternative assays for an assessment of endotoxin detection specificity.
    Dubczak J; Reid N; Tsuchiya M
    Eur J Pharm Sci; 2021 Apr; 159():105716. PubMed ID: 33454378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of method for endotoxin detection depends on nanoformulation.
    Dobrovolskaia MA; Neun BW; Clogston JD; Grossman JH; McNeil SE
    Nanomedicine (Lond); 2014; 9(12):1847-56. PubMed ID: 24359551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.